Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Neurizon Begins Dosing of NUZ-001 in HEALEY ALS Platform Trial

diseases, is pleased to announce that the first participant has been dosed in Regimen I of the HEALEY ALS Platform Trial evaluating Neurizon's lead candidate, NUZ-001, for the treatment of amyotrophic lateral sclerosis (ALS). HEALEY ALS Platform...

Ron Mayron Becomes Chairman of the Board of Matricelf Ltd

as Active Chairman of the Board of Directors. Mr. Mayron's appointment follows shareholder approval and submission of his formal Director Eligibility Declaration in accordance with the Israeli Companies Law. Extensive Leadership and Industry...

Unique Mouse Model Enables genOway to Transform Prediction of Antibody Therapies in Humans

antibodies in humans. The model allows scientists to rank different antibody candidates by how they are likely to perform, measure how effectively they target specific immune cells, and evaluate their potential to slow disease progression. This...

ARUP Laboratories Establishes Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

several assays using capillary blood microsamples, which are collected using the Tasso device, and will serve as the performing laboratory of the combined service. The new partnership with Tasso is an additional element of ARUP's robust offerings...

CollPlant Expands Its rhCollagen 3D Bioprinting Portfolio Through the Launch of Ready-to-Print BioFlex

developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen) platform, today announced the launch of BioFlex, a ready-to-print rhCollagen-based kit designed for Digital Light Processing (DLP) 3D...

With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and GlycoScape™ software now support...

SECuRE trial update: Another participant with negative PSMA PET and undetectable PSA

The most recent data released from the Co-PSMA study clearly establishes that 64Cu-SAR-bisPSMA considerably outperforms its competitors in detecting prostate cancer recurrence and sheds light on the importance of the improved lesion detection,...

PureTech Secures U.S. and EU Orphan Designations for Deupirfenidone (LYT-100) in IPF

PureTech Health plc a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, announced that the U.S. Food and Drug Administration (FDA) and European Commission have granted Orphan Drug...

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

& Decision Modelling, who will lead evidence synthesis, advanced statistical analysis, and economic modelling that inform market access and Health Technology Appraisal (HTA) decision making within the Access Consulting and Health Economics and...

New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday

studies. This is a significant finding for patients, as it offers a potentially reliable strategy for providers and transformative opportunity for patients to manage their IBD journey even when treatment is interrupted.” “In clinical practice,...

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

factory for drug discovery programs, integrating a chemical compound repository with a high-throughput screening (HTS) platform. Its mission is to act as a bridge between academic research and pharmaceutical development, with a particular focus on...

A Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression.

in vitro and in vivo models into clinical studies. Their 30 years of foundational research now provide a robust platform for launching a new generation of anticancer treatments based on isotopic modulation. HYD LLC is actively seeking investment...

FDA Grants KORU Medical Systems 510(k) Clearance for RYSTIGGO® Delivery via FreedomEDGE® Infusion System

life-changing therapies wherever patients are treated. This clearance aligns with our strategy to extend the Freedom platform to more drug therapies, more settings, and more patients.” KORU Medical’s Freedom Infusion System enables, simplifies, and...

Tonix Pharmaceuticals presented Phase 3 RESILIENT data on TONMYA™ (cyclobenzaprine HCl sublingual tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

M.D. highlight TONMYA'S role as a centrally-acting, differentiated non-opioid treatment. TONMYA'S unique sublingual formulation is designed for bedtime administration and to bypass first-pass metabolism, resulting in a pharmacokinetic profile that...

China approves Libevitug, first-in-class therapy for hepatitis D

the European Association for the Study of the Liver (EASL) consistently identify HDV–HBV co-infection as the most severe form of chronic viral hepatitis due to rapid progression towards liver cirrhosis, hepatocellular carcinoma and liver-related...

Correction — Privo Technologies

company developing localized therapies for solid tumors using its proprietary nanoengineered delivery platform, focused on improving outcomes while preserving quality of life. For more information please visit, www.privotechnologies.com

HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline

development and manufacturing services, including cell line development, process and bioassay development, drug product formulation development, and GMP manufacturing. The collaboration is designed to accelerate clinical translation, enhance CMC...

CoreAge Rx broadens GLP-1 access in support of New Year weight loss initiatives

access to specialized in-person providers. As part of the New Year's expansion, CoreAge Rx is enhancing its digital platform, strengthening patient education resources, and optimizing fulfillment processes to ensure consistent medication...

OCuSOFT Inc. introduces Retaine® Omega Forté™, a liquid supplement designed to deliver superior nutritional support in the management of dry eye

cleansing agent, proudly announces the launch of Retaine® Omega Forté™, a highly purified omega-3 nutritional supplement formulated to provide superior support for individuals suffering from dry eye symptoms. Formulated with patient compliance and...

BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

liposuction, sclerotherapy, and dermal fillers, and includes: Advanced Bruise Cream: A clinically proven, proprietary formula designed to accelerate skin healing and minimize bruising. Enriched with Arnica, Vitamin K, Emu Oil, Vitamin E, and Green...